Provided by Tiger Trade Technology Pte. Ltd.

NovoCure

15.48
-0.1500-0.96%
Volume:654.68K
Turnover:10.18M
Market Cap:1.80B
PE:-11.83
High:16.07
Open:15.26
Low:15.10
Close:15.63
52wk High:21.45
52wk Low:9.82
Shares:116.45M
Float Shares:96.42M
Volume Ratio:0.79
T/O Rate:0.68%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3082
EPS(LYR):-1.2221
ROE:-43.22%
ROA:-9.26%
PB:5.33
PE(LYR):-12.67

Loading ...

NovoCure Phase 3 Glioblastoma Trial Misses Overall Survival Endpoint

MT Newswires Live
·
Jun 18

Novocure says Phase 3 TRIDENT trial did not meet primary endpoint

TIPRANKS
·
Jun 18

Novocure's cancer treatment fails to meet late-stage trial goal

Reuters
·
Jun 18

Novocure says Phase 3 TRIDENT glioblastoma trial misses overall survival endpoint for earlier TTFields use

Reuters
·
Jun 18

Novocure Announces Topline Data From the Phase 3 Trident Trial Evaluating Earlier Use of Tumor Treating Fields Therapy in Newly Diagnosed Glioblastoma

THOMSON REUTERS
·
Jun 18

Novocure - Early Start Arm Median Overall Survival 17.7 Months VS 17.5 Months in Maintenance Start Arm

THOMSON REUTERS
·
Jun 18

Novocure - No New Safety Signals Observed in Trident Trial; Early Ttfields Initiation Feasible

THOMSON REUTERS
·
Jun 18

Novocure - Trident Trial Does Not Meet Primary Endpoint for Overall Survival

THOMSON REUTERS
·
Jun 18

NovoCure (NVCR) Appoints Frank Leonard To Its Board After Shareholder Vote

Simply Wall St.
·
Jun 17

Have Insiders Sold NovoCure Shares Recently?

Simply Wall St.
·
Jun 07

NovoCure Shareholders Approve Directors, Auditor and Incentive Plan

TIPRANKS
·
Jun 06

A Look At NovoCure (NVCR) Valuation As Shares Show Mixed Recent Performance

Simply Wall St.
·
Jun 02

Lifeward names Keith D. Rose chief medical officer

Reuters
·
May 19

Novocure Is Maintained at Equal-Weight by Wells Fargo

Dow Jones
·
May 05

Novocure price target raised to $17 from $13.50 at Wells Fargo

TIPRANKS
·
May 04

NovoCure’s Optune Pax Win And TRIDENT Data Shape Growth Outlook

Simply Wall St.
·
May 02

Stock Track | NovoCure Soars 5.13% Intraday After Evercore ISI Raises Price Target to $20

Stock Track
·
May 01

Novocure Is Maintained at Outperform by Evercore ISI Group

Dow Jones
·
May 01

Novocure price target raised to $20 from $16 at Evercore ISI

TIPRANKS
·
May 01

Analysts Are Bullish on These Healthcare Stocks: NovoCure (NVCR), Verano Holdings (VRNO)

TIPRANKS
·
May 01